LY2562175 |
An FXR agonist (EC50 = 193 nM in a reporter assay); selective for FXR over… |
10 mg |
28912-10 |
More Info
|
LY2562175 |
An FXR agonist (EC50 = 193 nM in a reporter assay); selective for FXR over… |
25 mg |
28912-25 |
More Info
|
LY2562175 |
An FXR agonist (EC50 = 193 nM in a reporter assay); selective for FXR over… |
5 mg |
28912-5 |
More Info
|
LY2603618 |
A Chk1 inhibitor (IC50 = 7 nM) that prevents the repair of DNA caused by D… |
10 mg |
20351-10 |
More Info
|
LY2603618 |
A Chk1 inhibitor (IC50 = 7 nM) that prevents the repair of DNA caused by D… |
25 mg |
20351-25 |
More Info
|
LY2603618 |
A Chk1 inhibitor (IC50 = 7 nM) that prevents the repair of DNA caused by D… |
5 mg |
20351-5 |
More Info
|
LY2603618 |
A Chk1 inhibitor (IC50 = 7 nM) that prevents the repair of DNA caused by D… |
50 mg |
20351-50 |
More Info
|
LY2606368 |
A Chk1 inhibitor (Ki = 0.9 nM); IC50 values of 2 / M checkpoint in HeLa ce… |
1 mg |
21490-1 |
More Info
|
LY2606368 |
A Chk1 inhibitor (Ki = 0.9 nM); IC50 values of 2 / M checkpoint in HeLa ce… |
10 mg |
21490-10 |
More Info
|
LY2606368 |
A Chk1 inhibitor (Ki = 0.9 nM); IC50 values of 2 / M checkpoint in HeLa ce… |
25 mg |
21490-25 |
More Info
|
LY2606368 |
A Chk1 inhibitor (Ki = 0.9 nM); IC50 values of 2 / M checkpoint in HeLa ce… |
5 mg |
21490-5 |
More Info
|
LY2608204 |
An activator of glucokinase (EC50 = 42 nM); stimulates glucose metabolism… |
1 mg |
22914-1 |
More Info
|
LY2608204 |
An activator of glucokinase (EC50 = 42 nM); stimulates glucose metabolism… |
10 mg |
22914-10 |
More Info
|
LY2608204 |
An activator of glucokinase (EC50 = 42 nM); stimulates glucose metabolism… |
25 mg |
22914-25 |
More Info
|
LY2608204 |
An activator of glucokinase (EC50 = 42 nM); stimulates glucose metabolism… |
5 mg |
22914-5 |
More Info
|
LY272015 |
A 5-HT2B receptor antagonist; binds to 5-HT2B receptors in isolated rat fu… |
1 mg |
31471-1 |
More Info
|
LY272015 |
A 5-HT2B receptor antagonist; binds to 5-HT2B receptors in isolated rat fu… |
5 mg |
31471-5 |
More Info
|
LY2784544 |
A potent, ATP-competitive inhibitor of JAK2 that less effectively inhibits… |
1 mg |
16705-1 |
More Info
|
LY2784544 |
A potent, ATP-competitive inhibitor of JAK2 that less effectively inhibits… |
10 mg |
16705-10 |
More Info
|
LY2784544 |
A potent, ATP-competitive inhibitor of JAK2 that less effectively inhibits… |
25 mg |
16705-25 |
More Info
|
LY2784544 |
A potent, ATP-competitive inhibitor of JAK2 that less effectively inhibits… |
5 mg |
16705-5 |
More Info
|
LY2795050 |
A κ-opioid receptor antagonist (Ki = 0.722 nM); selective for the KO… |
1 mg |
33604-1 |
More Info
|
LY2795050 |
A κ-opioid receptor antagonist (Ki = 0.722 nM); selective for the KO… |
10 mg |
33604-10 |
More Info
|
LY2795050 |
A κ-opioid receptor antagonist (Ki = 0.722 nM); selective for the KO… |
25 mg |
33604-25 |
More Info
|
LY2795050 |
A κ-opioid receptor antagonist (Ki = 0.722 nM); selective for the KO… |
5 mg |
33604-5 |
More Info
|
LY2801653 |
A MET kinase inhibitor (Ki = 2 nM); inhibits MST1R, Axl, MNK1 / 2, FLT3, D… |
1 mg |
25978-1 |
More Info
|
LY2801653 |
A MET kinase inhibitor (Ki = 2 nM); inhibits MST1R, Axl, MNK1 / 2, FLT3, D… |
10 mg |
25978-10 |
More Info
|
LY2801653 |
A MET kinase inhibitor (Ki = 2 nM); inhibits MST1R, Axl, MNK1 / 2, FLT3, D… |
5 mg |
25978-5 |
More Info
|
LY2801653 |
A MET kinase inhibitor (Ki = 2 nM); inhibits MST1R, Axl, MNK1 / 2, FLT3, D… |
50 mg |
25978-50 |
More Info
|
LY2811376 |
A non-peptide inhibitor of BACE1 (IC50 = 239 nM) that demonstrates ~10-fol… |
1 mg |
16712-1 |
More Info
|
LY2811376 |
A non-peptide inhibitor of BACE1 (IC50 = 239 nM) that demonstrates ~10-fol… |
10 mg |
16712-10 |
More Info
|
LY2811376 |
A non-peptide inhibitor of BACE1 (IC50 = 239 nM) that demonstrates ~10-fol… |
5 mg |
16712-5 |
More Info
|
LY2811376 |
A non-peptide inhibitor of BACE1 (IC50 = 239 nM) that demonstrates ~10-fol… |
50 mg |
16712-50 |
More Info
|
LY2828360 |
A CB2 agonist (Ki = 40.3 nM) selectively activates CB2 over CB1 in a GTP&g… |
1 mg |
26791-1 |
More Info
|
LY2828360 |
A CB2 agonist (Ki = 40.3 nM) selectively activates CB2 over CB1 in a GTP&g… |
10 mg |
26791-10 |
More Info
|
LY2828360 |
A CB2 agonist (Ki = 40.3 nM) selectively activates CB2 over CB1 in a GTP&g… |
25 mg |
26791-25 |
More Info
|
LY2828360 |
A CB2 agonist (Ki = 40.3 nM) selectively activates CB2 over CB1 in a GTP&g… |
5 mg |
26791-5 |
More Info
|
LY2835219 |
An orally bioavailable dual inhibitor of Cdk4 and Cdk6 (IC50s = 2 and 10 n… |
1 mg |
21560-1 |
More Info
|
LY2835219 |
An orally bioavailable dual inhibitor of Cdk4 and Cdk6 (IC50s = 2 and 10 n… |
10 mg |
21560-10 |
More Info
|
LY2835219 |
An orally bioavailable dual inhibitor of Cdk4 and Cdk6 (IC50s = 2 and 10 n… |
25 mg |
21560-25 |
More Info
|
LY2835219 |
An orally bioavailable dual inhibitor of Cdk4 and Cdk6 (IC50s = 2 and 10 n… |
5 mg |
21560-5 |
More Info
|
LY2857785 |
A Cdk9 inhibitor (IC50 = 0.011 µM); inhibits Cdk8 and Cdk7 (IC50s =… |
1 mg |
34880-1 |
More Info
|
LY2857785 |
A Cdk9 inhibitor (IC50 = 0.011 µM); inhibits Cdk8 and Cdk7 (IC50s =… |
10 mg |
34880-10 |
More Info
|
LY2857785 |
A Cdk9 inhibitor (IC50 = 0.011 µM); inhibits Cdk8 and Cdk7 (IC50s =… |
25 mg |
34880-25 |
More Info
|
LY2857785 |
A Cdk9 inhibitor (IC50 = 0.011 µM); inhibits Cdk8 and Cdk7 (IC50s =… |
5 mg |
34880-5 |
More Info
|
LY2874455 |
A pan-FGFR inhibitor (IC50s = 2.8, 2.6, 6.4, 6, and 7 nM for FGFR1, FGFR2,… |
1 mg |
20843-1 |
More Info
|
LY2874455 |
A pan-FGFR inhibitor (IC50s = 2.8, 2.6, 6.4, 6, and 7 nM for FGFR1, FGFR2,… |
10 mg |
20843-10 |
More Info
|
LY2874455 |
A pan-FGFR inhibitor (IC50s = 2.8, 2.6, 6.4, 6, and 7 nM for FGFR1, FGFR2,… |
25 mg |
20843-25 |
More Info
|
LY2874455 |
A pan-FGFR inhibitor (IC50s = 2.8, 2.6, 6.4, 6, and 7 nM for FGFR1, FGFR2,… |
5 mg |
20843-5 |
More Info
|
LY2886721 |
Selective inhibitor of BACE (IC50 = 20 nM for recombinant hBACE1) |
1 mg |
21599-1 |
More Info
|